Terms: = Lung cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7
1327 results:
1. Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early lung cancer.
Borghetti P; Costantino G; Santoro V; Mataj E; Singh N; Vitali P; Greco D; Volpi G; Sepulcri M; Guida C; Tomasi C; Buglione M; Nardone V
In Vivo; 2024; 38(3):1359-1366. PubMed ID: 38688600
[TBL] [Abstract] [Full Text] [Related]
2. Temporal trends and regional variability in BRAF and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.
Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
[TBL] [Abstract] [Full Text] [Related]
3. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
[TBL] [Abstract] [Full Text] [Related]
4. ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.
Zhang R; Zhu G; Li Z; Meng Z; Huang H; Ding C; Wang Y; Chen C; Li Y; Liu H; Chen J
Front Immunol; 2024; 15():1382231. PubMed ID: 38646528
[TBL] [Abstract] [Full Text] [Related]
5. Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells.
Zhuang X; Woods J; Ji Y; Scheich S; Mo F; Rajagopalan S; Coulibaly ZA; Voss M; Urlaub H; Staudt LM; Pan KT; Long EO
Cell Rep; 2024 Apr; 43(4):114105. PubMed ID: 38619967
[TBL] [Abstract] [Full Text] [Related]
6. A combined subsegmentectomy of right S9 + 10b with single direction thoracoscopic surgery.
Shen C; Liu C
J Cardiothorac Surg; 2024 Apr; 19(1):206. PubMed ID: 38614999
[TBL] [Abstract] [Full Text] [Related]
7. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
[TBL] [Abstract] [Full Text] [Related]
8. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
[TBL] [Abstract] [Full Text] [Related]
9. Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Sitthideatphaiboon P; Nantavithya C; Chantranuwat P; Vinayanuwattikun C; Sriuranpong V
Sci Rep; 2024 Mar; 14(1):6146. PubMed ID: 38480816
[TBL] [Abstract] [Full Text] [Related]
10. Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition.
Wang X; Zhang X; Liu Z; Zhao N; Li X; Su P; Zheng G; Zhang X; Wang H; Zhang Y
Int J Biochem Cell Biol; 2024 Apr; 169():106557. PubMed ID: 38460905
[TBL] [Abstract] [Full Text] [Related]
11. Carnosic Acid against lung cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
[TBL] [Abstract] [Full Text] [Related]
12. IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer.
Wu J; Zhang Q; Wu J; Yang Z; Liu X; Lou C; Wang X; Peng J; Zhang J; Shang Z; Xiao J; Wang N; Zhang R; Zhou J; Wang Y; Hu Z; Zhang R; Zhang J; Zeng Z
J Cell Mol Med; 2024 Feb; 28(4):e18185. PubMed ID: 38396325
[TBL] [Abstract] [Full Text] [Related]
13. Is there a prognostic difference among stage I lung adenocarcinoma patients with different BRAF-mutation status?
Ma SS; Wang RR; Peng Q; Liu Y; Qian JY; Li MJ; Li K; Huang ZY; Wu LL; Xie D
Thorac Cancer; 2024 Mar; 15(9):715-721. PubMed ID: 38362771
[TBL] [Abstract] [Full Text] [Related]
14. Tumor microenvironment(TME) and single-source dual-energy CT(ssDECT) on assessment of inconformity between RECIST1.1 and pathological remission in neoadjuvant immunotherapy of NSCLC.
Sun C; Ma X; Meng F; Chen X; Wang X; Sun W; Xu Y; He H; Zhang H; Ma K
Neoplasia; 2024 Apr; 50():100977. PubMed ID: 38354688
[TBL] [Abstract] [Full Text] [Related]
15. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
[TBL] [Abstract] [Full Text] [Related]
16. Single-cell sequencing reveals the immune landscape of breast cancer patients with brain metastasis.
Zhou H; He X; Huang J; Zhong Y; Zhang L; Ao X; Zhao H; Hu S; Li H; Huang J; Huang H; Liang H
Thorac Cancer; 2024 Mar; 15(9):702-714. PubMed ID: 38316626
[TBL] [Abstract] [Full Text] [Related]
17. [Surgical Resection and Adjuvant Chemotherapy for Early Multiple Peritoneal Recurrence after Rejection of Hepatocellular Carcinoma-A Case Report].
Yamaguchi S; Onoe T; Fujii T; Shibata Y; Tazuma S; Akimoto S; Sada H; Shimada N; Tazawa H; Suzuki T; Sudo T; Shimizu Y; Tashiro H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1450-1452. PubMed ID: 38303304
[TBL] [Abstract] [Full Text] [Related]
18. [The Usefulness of RFA as a Conversion Therapy after Molecular Targeted Therapy for Advanced Hepatocellular Carcinoma-A Case of Long-Term Survival with Multidisciplinary Treatment].
Matsumoto T; Hayashi H; Adachi Y; Kanemitsu K; Tajiri T; Yumoto S; Ogawa D; Shiraishi Y; Takematsu T; Tsukamoto M; Miyata T; Nakagawa S; Mima K; Nitta H; Baba H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1928-1930. PubMed ID: 38303255
[TBL] [Abstract] [Full Text] [Related]
19. Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway.
Zhang C; Jin Y
Hum Exp Toxicol; 2024; 43():9603271241229140. PubMed ID: 38289222
[TBL] [Abstract] [Full Text] [Related]
20. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
[Next]
